Please login to the form below

Not currently logged in
Email:
Password:

Bone Therapeutics

This page shows the latest Bone Therapeutics news and features for those working in and with pharma, biotech and healthcare.

BioMimetic bone graft wins panel support

A US Food and Drug Administration committee has voted in support of BioMimetic Therapeutics' Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures. ... The US Food and Drug Administration's (FDA) Orthopaedic

Latest news

  • Malcolm's Market Eye: 7 to 13 July 2007

    Now a study in US publication Diabetes Care has suggested that Avandia could reduce bone mineral density in men. ... Northwest Therapeutics gets Swiss green light for brain cancer vaccine. Northwest Therapeutics saw its share price rise by 38p to 140p on

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Bone Therapeutics strengthens board with new chairman Bone Therapeutics strengthens board with new chairman

    Jean Stéphenne joins the cell therapy company from TiGenix. Belgian biotechnology company Bone Therapeutics has appointed Jean Stéphenne as its new chairman of the board of directors, succeeding Steve Swinson in ... Thomas Lienard, chief executive

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    He joins the Norwegian biotech from Bone Therapeutics. Zelluna Therapeutics has appointed its new chief executive officer in the form of Miguel Forte. ... Prior to his new role, Forte has held roles for Bone Therapeutics, TxCell, the European Medicines

  • Bone Therapeutics strengthens clinical development team Bone Therapeutics strengthens clinical development team

    Dr Miguel Forte joins the firm as chief medical officer. Dr Miguel Forte has joined Belgium biotechnology company Bone Therapeutics as its new chief medical officer. ... I look forward to working with the Bone Therapeutics team to realise the potential

  • Bone Therapeutics looks to Pfizer for clinical head Bone Therapeutics looks to Pfizer for clinical head

    Guy Heynen has 35 years of industry experience. Bone Therapeutics, the regenerative therapy company for bone diseases and orthopaedics, has named Guy Heynen as its chief clinical and regulatory officer. ... CEO of Bone Therapeutics Enrico Bastianello said

  • Wim Goemaere appointed CFO at Bone Therapeutics Wim Goemaere appointed CFO at Bone Therapeutics

    He joins from agricultural biotech firm Devgen. Bone Therapeutics yesterday announced that Wim Goemaere is to join the company as chief financial officer. ... Bone Therapeutics is also developing an allogeneic bone cell therapy product called allob.

More from appointments
Approximately 4 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...